A New Era of Impact in Global Health Sciences
To explore how universities, specifically UC San Francisco (UCSF), can maximize their impact in this new era, the Institute for Global Health Sciences (IGHS) will host a day-long symposium on Friday, January 26 in Mission Bay. The symposium, “A new era in global health sciences,” features UCSF leaders who will discuss and debate the new priorities for academic global health and showcase how UCSF is responding to these challenges.
•Harvey V. Fineberg, MD, PhD, president of the Gordon and Betty Moore Foundation and former president of the Institute of Medicine, will give the keynote address.
•The symposium will feature the U.S. launch of the third edition of Disease Control Priorities for Developing Countries (DCP3). Series editor Dean Jamison, UCSF professor emeritus, will moderate a panel that includes Jaime Sepulveda, executive director of IGHS, and other UCSF authors and contributors to the DCP3 series.
•Kirsten Bibbins Domingo, Vice Dean for Population Health and Health Equity, School of Medicine, will moderate a panel discussing new priority areas for global health where UCSF is playing a leading role. UCSF faculty Renee Hsia, Catherine Juillard and Susan Meffert, leaders in global emergency medicine, surgery, and mental health, are panelists.
•Paul Volberding, director of the AIDS Research Institute, will moderate a panel exploring the potential for transdisciplinary research approaches to unlock sustainable solutions to global health problems as well as the challenges academics face when working across associated traditional silos with Michael McCune, former head of the Division of Experimental Medicine, and Dana van Gorder, an HIV activist and leader of Project Inform, that will look at lessons learned from UCSF’s transdisciplinary research in the early days of the HIV epidemic. A separate group will also discuss how those lesson apply to current efforts to build a transdisciplinary research program around tuberculosis.
•Sir Richard Feachem, director of the IGHS Global Health Group, will present closing remarks.